Newest
BETR ▼ sold $13K · Tuffin Paula filed 2d agoBETR ▼ sold $14K · Nicholas J. Calamari filed 2d agoFBK ▲ bought $716K · INGRAM ORRIN H II filed 2d agoFBK ▲ bought $821K · INGRAM ORRIN H II filed 2d agoBEN ▼ sold $5.0M · FRANKLIN TEMPLETON INC filed 2d agoNAD ▼ sold $338K · Robert Young L filed 3d agoWSBC ▼ sold $15K · Rep. Michael A. Rulli filed 4d agoGOOG ▼ sold $100K · Rep. Michael A. Rulli filed 4d agoWMT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoVSAT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoTYG ▼ sold $15K · Rep. Jonathan L. Jackson filed 4d agoGH ▲ bought $50K · Rep. Jonathan L. Jackson filed 4d agoEL ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoDDOG ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoCPRT ▼ sold $553K · Morefield Diane M filed 4d agoPTON ▼ sold $154K · Kirol Charles Peter filed 4d agoEME ▲ bought $1K · MCEVOY M KEVIN filed 4d agoEME ▲ bought $826 · MCEVOY M KEVIN filed 4d ago

Company / CIK 0002058707

Attovia Therapeutics, Inc.

Ticker
ATTO
Insiders on file
13
Federal contracts on record
none matched
Lobbying filings on record
none matched
SEC filings
EDGAR ↗
Latest trade on record
August 6, 2026

Attovia Therapeutics, Inc. (ATTO) has 13 insiders on file who disclosed 90 transactions in the last 12 months (9 open-market buys, 45 sales, about $56.9M at reported prices). No federal contract award that started in the last 180 days was found for a recipient with exactly this name; no lobbying filing names it as client this year.

Last updated August 13, 2026 · Sources: SEC EDGAR; USAspending; Senate LDA

Attovia Therapeutics, Inc. in charts

Who is trading this stock

Which people account for the buying and selling over the last 12 months?

BoughtSold

6 people account for the disclosed buying and selling in Attovia Therapeutics, Inc. over the last 12 months; the most active is GOLDMAN SACHS GROUP INC with $13M.

Insiders

NameRoleRowsBoughtSoldLast filed
GOLDMAN SACHS GROUP INCInsider29223August 13, 2026
WALSH COLINDirector29022August 13, 2026
SanofiInsider310August 12, 2026
venBio Global Strategic Fund IV, L.P.Insider710August 10, 2026
Deep Track Biotechnology Master Fund, Ltd.Insider200August 10, 2026
Redmile Group, LLCInsider420August 7, 2026
Attovia Therapeutics, Inc.President and CEO200August 6, 2026
Chen HubertChief Medical Officer100August 6, 2026
Veiby PetterChief Scientific Officer100August 6, 2026
Odrowaz ZanetaChief Business Officer100August 6, 2026
GOLD MITCHELLDirector100August 6, 2026
You AngieDirector100August 6, 2026
Frazier Life Sciences XI, L.P.Insider910August 6, 2026

Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.

Insider transactions

Download CSV90 rows · 31 KB · insider and congressional rows for this ticker · all downloads

FilerSecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
WALSH COLINATTOExchange CAugust 6, 2026August 13, 20267d4,445,275——lateindirectderivativeForm 4 ↗
WALSH COLINATTOExchange CAugust 6, 2026August 13, 20267d18,181,830——lateindirectderivativeForm 4 ↗
WALSH COLINATTOOther PAugust 6, 2026August 13, 20267d500,000$17$8.5Mlateindirectalso in another filingForm 4 ↗
WALSH COLINATTOExchange CAugust 6, 2026August 13, 20267d478,498——lateindirectForm 4 ↗
WALSH COLINATTOExchange CAugust 6, 2026August 13, 20267d1,957,134——lateindirectForm 4 ↗
WALSH COLINATTOOther SAugust 5, 2026August 13, 20268d76,418$21$1.6Mlateindirectalso in another filingForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d6,763$22$146KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d100$22$2,199lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d1,163$22$26KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d700$22$15KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d200$22$4,410lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d443$22$9,649lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d300$21$6,252lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d1,040$22$23KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d1,180$22$26KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d400$22$8,808lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d6,970$22$154KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d672$22$15KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d753$22$17KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d100$22$2,211lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d480$22$10KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d200$22$4,420lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d3,402$22$75KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d1,556$22$34KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d200$22$4,410lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d1,332$22$29KlateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d447$22$9,776lateindirectForm 4 ↗
WALSH COLINATTOSell SAugust 5, 2026August 13, 20268d988$22$22KlateindirectForm 4 ↗
WALSH COLINATTOOther PAugust 5, 2026August 13, 20268d85,000$21$1.8Mlateindirectalso in another filingForm 4 ↗
GOLDMAN SACHS GROUP INCATTOExchange CAugust 6, 2026August 13, 20267d4,445,275——lateindirectderivativeForm 4 ↗
GOLDMAN SACHS GROUP INCATTOExchange CAugust 6, 2026August 13, 20267d18,181,830——lateindirectderivativeForm 4 ↗
GOLDMAN SACHS GROUP INCATTOBuy PAugust 6, 2026August 13, 20267d500,000$17$8.5MlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOExchange CAugust 6, 2026August 13, 20267d478,498——lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOExchange CAugust 6, 2026August 13, 20267d1,957,134——lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d76,418$21$1.6MlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d6,763$22$146KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d100$22$2,199lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d1,163$22$26KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d700$22$15KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d200$22$4,410lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d443$22$9,649lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d300$21$6,252lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d1,040$22$23KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d1,180$22$26KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d400$22$8,808lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d6,970$22$154KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d672$22$15KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d753$22$17KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d100$22$2,211lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d480$22$10KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d200$22$4,420lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d3,402$22$75KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d1,556$22$34KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d200$22$4,410lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d1,332$22$29KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d447$22$9,776lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOSell SAugust 5, 2026August 13, 20268d988$22$22KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCATTOBuy PAugust 5, 2026August 13, 20268d85,000$21$1.8MlateindirectForm 4 ↗
Deep Track Biotechnology Master Fund, Ltd.ATTOExchange CAugust 6, 2026August 10, 20264d18,181,818——derivativeForm 4 ↗
Deep Track Biotechnology Master Fund, Ltd.ATTOExchange CAugust 6, 2026August 10, 20264d1,957,138——Form 4 ↗
venBio Global Strategic Fund IV, L.P.ATTOExchange CAugust 6, 2026August 10, 20264d6,179,219——derivativeForm 4 ↗
venBio Global Strategic Fund IV, L.P.ATTOExchange CAugust 6, 2026August 10, 20264d7,636,362——derivativeForm 4 ↗
venBio Global Strategic Fund IV, L.P.ATTOExchange CAugust 6, 2026August 10, 20264d21,477,273——derivativeForm 4 ↗
venBio Global Strategic Fund IV, L.P.ATTOBuy PAugust 6, 2026August 10, 20264d382,352$17$6.5MForm 4 ↗
venBio Global Strategic Fund IV, L.P.ATTOExchange CAugust 6, 2026August 10, 20264d665,147——Form 4 ↗
venBio Global Strategic Fund IV, L.P.ATTOExchange CAugust 6, 2026August 10, 20264d821,998——Form 4 ↗
venBio Global Strategic Fund IV, L.P.ATTOExchange CAugust 6, 2026August 10, 20264d2,311,870——Form 4 ↗
Redmile Group, LLCATTOExchange CAugust 6, 2026August 7, 20261d782,854——indirectderivativeForm 4 ↗
Redmile Group, LLCATTOBuy PAugust 6, 2026August 7, 20261d400,000$17$6.8MindirectForm 4 ↗
Redmile Group, LLCATTOBuy PAugust 6, 2026August 7, 20261d200,000$17$3.4MForm 4 ↗
Redmile Group, LLCATTOExchange CAugust 6, 2026August 7, 20261d782,854——indirectForm 4 ↗
SanofiATTOExchange CAugust 6, 2026August 7, 20261d782,855——indirectderivativeForm 4 ↗
SanofiATTOBuy PAugust 6, 2026August 7, 20261d300,000$17$5.1MindirectForm 4 ↗
SanofiATTOExchange CAugust 6, 2026August 7, 20261d782,855——indirectForm 4 ↗
Frazier Life Sciences XI, L.P.ATTOExchange CAugust 6, 2026August 6, 20260d8,930,685——derivativeForm 4 ↗
Frazier Life Sciences XI, L.P.ATTOExchange CAugust 6, 2026August 6, 20260d11,054,544——derivativeForm 4 ↗
Frazier Life Sciences XI, L.P.ATTOExchange CAugust 6, 2026August 6, 20260d14,772,727——derivativeForm 4 ↗
Frazier Life Sciences XI, L.P.ATTOExchange CAugust 6, 2026August 6, 20260d16,250,000——derivativeForm 4 ↗
Frazier Life Sciences XI, L.P.ATTOBuy PAugust 6, 2026August 6, 20260d588,235$17$10.0MForm 4 ↗
Frazier Life Sciences XI, L.P.ATTOExchange CAugust 6, 2026August 6, 20260d961,322——Form 4 ↗
Frazier Life Sciences XI, L.P.ATTOExchange CAugust 6, 2026August 6, 20260d1,189,940——Form 4 ↗
Frazier Life Sciences XI, L.P.ATTOExchange CAugust 6, 2026August 6, 20260d1,590,175——Form 4 ↗
Frazier Life Sciences XI, L.P.ATTOExchange CAugust 6, 2026August 6, 20260d1,749,192——Form 4 ↗
You AngieATTOOther AAugust 4, 2026August 6, 20262d27,000——derivativeForm 4 ↗
GOLD MITCHELLATTOOther AAugust 4, 2026August 6, 20262d27,000——derivativeForm 4 ↗
Odrowaz ZanetaATTOOther AAugust 4, 2026August 6, 20262d140,000——derivativeForm 4 ↗
Veiby PetterATTOOther AAugust 4, 2026August 6, 20262d140,000——derivativeForm 4 ↗
Chen HubertATTOOther AAugust 4, 2026August 6, 20262d140,000——derivativeForm 4 ↗
Attovia Therapeutics, Inc.ATTOOther AAugust 4, 2026August 6, 20262d140,000——derivativeForm 4 ↗
Attovia Therapeutics, Inc.ATTOOther AAugust 4, 2026August 6, 20262d538,300——derivativeForm 4 ↗

Federal contracts (USAspending, awards started in the last 180 days)

No contract award starting in the last 180 days was found for a recipient named exactly "Attovia Therapeutics, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.

Lobbying (Senate LDA, as client)

No LDA filing posted since October 2025 names "Attovia Therapeutics, Inc." as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.

Companies whose stock was traded by the same people who traded ATTO, by number of filers in common. It shows overlap in public filings and nothing else.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 41490August 6, 2026August 13, 2026Form 4 list on EDGAR

Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.

Not investment advice. Public records shown as filed; no recommendation is made or implied.